Luc Y Dirix1, Peter Van Dam, Annemie Prové
1Oncology Center, Multidisciplinary Breast Clinic, AZ (Algemeen Ziekenhuis) Sint-Augustinus, Antwerp, Belgium. luc.dirix@pandora.be
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Inflammatory breast cancer (IBC) has a distinct molecular profile compared to non-inflammatory breast cancer, suggesting a different disease origin. Understanding these molecular differences may lead to targeted therapies for this aggressive cancer.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: